From crisis to opportunity: A perspective on the heparin crisisSASISEKHARAN, Ram; SHRIVER, Zachary.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 854-858, issn 0340-6245, 5 p.Conference Paper

Competitive Inhibition of Heparinase by Persulfonated Glycosaminoglycans: A Tool to Detect Heparin ContaminationAICH, Udayanath; SHRIVER, Zachary; THARAKARAMAN, Kannan et al.Analytical chemistry (Washington). 2011, Vol 83, Num 20, pp 7815-7822, issn 0003-2700, 8 p.Article

Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycansDONGFANG LIU; SHRIVER, Zachary; YIWEI QI et al.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 1, pp 67-78, issn 0094-6176Article

The Tainted Heparin Story: An UpdateGUERRINI, Marco; SHRIVER, Zachary; BISIO, Antonella et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 907-911, issn 0340-6245, 5 p.Conference Paper

Profiling the Glycoforms of the Intact α Subunit of Recombinant Human Chorionic Gonadotropin by High-Resolution Capillary Electrophoresis-Mass SpectrometryTHAKUR, Dipak; REJTAR, Tomas; KARGER, Barry L et al.Analytical chemistry (Washington). 2009, Vol 81, Num 21, pp 8900-8907, issn 0003-2700, 8 p.Article

Heparin and Heparan Sulfate: Analyzing Structure and MicroheterogeneitySHRIVER, Zachary; CAPILA, Ishan; VENKATARAMAN, Ganesh et al.Handbook of experimental pharmacology. 2012, Vol 207, pp 159-176, issn 0171-2004, 18 p.Article

Assessment of the quality and structural integrity of a complex glycoprotein mixture following extraction from the formulated biopharmaceutical drug productCUIHUA LIU; SHIMING DONG; XU, Xiao-Jin et al.Journal of pharmaceutical and biomedical analysis. 2011, Vol 54, Num 1, pp 27-36, issn 0731-7085, 10 p.Article

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsGUERRINI, Marco; BECCATI, Daniela; AL-HAKIM, Ali et al.Nature biotechnology (Print). 2008, Vol 26, Num 6, pp 669-675, issn 1087-0156, 7 p.Article

Contaminated heparin associated with adverse clinical events and activation of the contact systemKISHIMOTO, Takashi Kei; VISWANATHAN, Karthik; AL-HAKIM, Ali et al.The New England journal of medicine. 2008, Vol 358, Num 23, pp 2457-2467, issn 0028-4793, 11 p.Article

The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapyYANG YANG; MACLEOD, Veronica; VLODAVSKY, Israel et al.Blood. 2007, Vol 110, Num 6, pp 2041-2048, issn 0006-4971, 8 p.Article

Overexpression of Merlin in B16F10 mouse melanoma cells reduces their metastatic activity : Role of the cell surface heparan sulfate glycosaminoglycansGALCHEVA-GARGOVA, Zoya; ZHIDKOVA, Natalia; GEISLER, Sara et al.International journal of oncology. 2008, Vol 32, Num 6, pp 1237-1243, issn 1019-6439, 7 p.Article

Outbreak of Adverse Reactions Associated with Contaminated HeparinBLOSSOM, David B; KALLEN, Alexanderj; JONES, Marilyn et al.The New England journal of medicine. 2008, Vol 359, Num 25, pp 2674-2684, issn 0028-4793, 11 p.Article

Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and MiceMAINES, Taronna R; JAYARAMAN, Akita; ROMAN, Rahul et al.Science (Washington, D.C.). 2009, Vol 325, Num 5939, pp 484-487, issn 0036-8075, 4 p.Article